Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced.

Circulation · 2021 · PMC7834910 · PMID 33095032

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

We noted a nominally significant treatment-by–baseline eGFR interaction for the effect of empagliflozin on the eGFR slope, which was apparent irrespective of whether the analysis categorized patients into 2 or 5 eGFR subgroups.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.